Results
73,160 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Lewis Stephen EDirector |  RESRPC INCGrant or award | A | — 15.3K sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Lewis Stephen EDirector | RESRPC INC Grant or award | A | — 15.3K sh | Nov 4, 2026 |
| 21 | Kolstad Gary ADirector | RESRPC INC Grant or award | A | — 15.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Pershing John EChief Human Resources Officer |  BURLBurlington Stores, Inc.Grant or award | A | — 2,094 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Isely Raquel M.13D Group Member |  NGVCNatural Grocers by Vitamin Cottage, Inc.Option exercise | M | — 4,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Linnane Robert13D Group Member | NGVCNatural Grocers by Vitamin Cottage, Inc. Option exercise | M | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Sordello Steven JDirector |  COMPCompass, Inc.Option exercise | M | — 2,419 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Yi StevenDirector, See Remarks |  MAXMediaAlpha, Inc.Open-market sale · 10b5-1 plan | SELL | $2.05M 138.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Mewhorter Bryce LSVP & Corporate Controller |  ECLECOLAB INC.Tax withholding | F | — 1,344 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO |  AZRAzora Therapeutics, Inc. (DE)Derivative conversion | C | — 101.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner |  BROSDutch Bros Inc.Open-market sale · 10b5-1 plan | SELL | $134K 2,986 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 525 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Pitigoi CosminChief Financial Officer |  FLYWFlywire CorpOpen-market sale · 10b5-1 plan | SELL | $391K 19.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davies Benjamin R.CVP & Pres. Defense Systems |  NOCNORTHROP GRUMMAN CORP /DE/Option exercise | M | — 641 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Damon Doneene KDirector |  RWTREDWOOD TRUST INCOption exercise | M | $32K 10.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Lenkowsky AdamEVP, Chief Commercial Officer |  BMYBRISTOL MYERS SQUIBB COOption exercise | M | — 7,522 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Fang AndyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $906K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.62M 109.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Linnane Robert13D Group Member | NGVCNatural Grocers by Vitamin Cottage, Inc. Option exercise | M | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Gernetzke JamesChief Financial Officer |  EXODExodus Movement, Inc.Open-market sale | SELL | $28K 5,781 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Mewhorter Bryce LSVP & Corporate Controller | ECLECOLAB INC. Option exercise | M | — 2,948 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 |  Silbermann BenjaminDirector, 10% Owner |  PINSPINTEREST, INC.Open-market sale · 10b5-1 plan | SELL | $984K 46.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 21 | Schneider Andrea LPres & CEO Horizon Airlines |  ALKALASKA AIR GROUP, INC.Option exercise | M | — 378 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Woelkers Paul C.Director |  FDBCFIDELITY D & D BANCORP INCOpen-market sale | SELL | $35K 500 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 21 | Berry Jason MEVP & Chief Operating Officer | ALKALASKA AIR GROUP, INC. Option exercise | M | — 663 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Boone Jandeen MEVP, GC & Secretary | ECLECOLAB INC. Option exercise | M | — 1,769 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Tang MichaelSr VP, Secy & Chf Leg Ofc |  EMREMERSON ELECTRIC COGrant or award | A | — 28.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $272K 7,555 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $105K 1,502 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Keane Robert SDirector |  ATROASTRONICS CORPDerivative conversion | C | — 173.8K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $71K 996 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 21 | Saiki JulieChief Strategy Officer | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 626 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Saiki JulieChief Strategy Officer | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 626.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.15M 78.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 525.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Cook Melanie K.Director |  MBUUMALIBU BOATS, INC.Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Saadi Ryan H.Director, Chief Executive Officer, 10% Owner |  TVGNTevogen Inc.Grant or award | A | — 50.00M sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Open-market sale · 10b5-1 plan | SELL | $934K 46.9K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Krishnan Ram R.Executive Vice Pres & COO | EMREMERSON ELECTRIC CO Grant or award | A | — 60.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | DM Individual Aggregator, LLC10% Owner | BROSDutch Bros Inc. Open-market sale · 10b5-1 plan | SELL | $134K 2,986 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Hecht BethSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $256K 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |